Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1958 1
1962 1
1963 1
1965 2
1967 5
1968 1
1969 3
1970 1
1971 1
1972 2
1973 4
1974 4
1975 2
1976 1
1977 5
1978 8
1979 3
1980 3
1981 4
1982 2
1983 2
1984 4
1985 3
1986 6
1987 3
1988 9
1989 7
1990 5
1991 15
1992 12
1993 16
1994 12
1995 16
1996 14
1997 14
1998 20
1999 22
2000 31
2001 27
2002 37
2003 39
2004 47
2005 65
2006 66
2007 86
2008 135
2009 164
2010 131
2011 144
2012 181
2013 169
2014 187
2015 204
2016 202
2017 244
2018 297
2019 399
2020 451
2021 540
2022 654
2023 596
2024 630
2025 525

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,790 results

Results by year

Filters applied: . Clear all
Page 1
Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy.
Mukhopadhyay S, Huang HY, Lin Z, Ranieri M, Li S, Sahu S, Liu Y, Ban Y, Guidry K, Hu H, Lopez A, Sherman F, Tan YJ, Lee YT, Armstrong AP, Dolgalev I, Sahu P, Zhang T, Lu W, Gray NS, Christensen JG, Tang TT, Velcheti V, Khodadadi-Jamayran A, Wong KK, Neel BG. Mukhopadhyay S, et al. Among authors: tang tt. Cancer Res. 2023 Dec 15;83(24):4095-4111. doi: 10.1158/0008-5472.CAN-23-2729. Cancer Res. 2023. PMID: 37729426 Free PMC article.
YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies.
Chen Z, Zeng C, Yang L, Che Y, Chen M, Sau L, Wang B, Zhou K, Chen Y, Qing Y, Shen C, Zhang T, Wunderlich M, Wu D, Li W, Wang K, Leung K, Sun M, Tang T, He X, Zhang L, Swaminathan S, Mulloy JC, Müschen M, Huang H, Weng H, Xiao G, Deng X, Chen J. Chen Z, et al. Among authors: tang t. Cell. 2025 Jan 23;188(2):331-351.e30. doi: 10.1016/j.cell.2024.11.007. Epub 2024 Dec 17. Cell. 2025. PMID: 39694037
A phase I/II trial of WT1-specific TCR gene therapy for patients with acute myeloid leukemia and active disease post-allogeneic hematopoietic cell transplantation: skewing towards NK-like phenotype impairs T cell function and persistence.
Mazziotta F, Martin LE, Egan DN, Bar M, Kinsella S, Paulson KG, Voillet V, Lahman MC, Hunter D, Schmitt TM, Duerkopp N, Yeung CCS, Tang TH, Gottardo R, Asano Y, Wilcox EC, Lee B, Zhang T, Lopedote P, Penter L, Wu CJ, Milano F, Greenberg PD, Chapuis AG. Mazziotta F, et al. Among authors: tang th. Nat Commun. 2025 Jun 5;16(1):5214. doi: 10.1038/s41467-025-60394-0. Nat Commun. 2025. PMID: 40473616 Free PMC article. Clinical Trial.
ALKBH1 drives tumorigenesis and drug resistance via tRNA decoding reprogramming and codon-biased translation.
Shen C, Che Y, Zhou K, Wang K, Li W, Xue D, Wu T, Yang L, Chen M, Sheng Y, Zhang C, Robinson S, Chen H, Sau L, Chen Z, Wunderlich M, Han L, Tang T, Qing Y, Wu D, Sun M, Leung K, Dąbrowska K, Pirrotte P, Hu YC, Ghoda LY, Zhang B, Mulloy JC, Wei M, Marcucci G, He C, Deng X, Chen J. Shen C, et al. Among authors: tang t. Cancer Discov. 2025 Aug 4:10.1158/2159-8290.CD-24-1043. doi: 10.1158/2159-8290.CD-24-1043. Online ahead of print. Cancer Discov. 2025. PMID: 40747882 Free PMC article.
5,790 results